Nurexone Biologic (Tsxv: Nrx) (Fse: J90)
Biotechnology Research · 11 Employees
Email Address: info@nurexone.com
- Overview
- Employees
Access 12 Verified Employees Profiles for Nurexone Biologic (Tsxv: Nrx) (Fse: J90)Unlock Free Contacts Now
About
NurExone Biologic is developing a revolutionary biological exosome based technology drug platform to treat damage in the Central Nerve System.
The breakthrough exosome-based technology was proven in preclinical studies to have the potential to treat spinal cord injuries.
Website
Year Founded
2020
Social Media
Linkedin
Industry
Biotechnology Research
HQ Location
Haifa, IL
Keywords
--
Location
- Haifa, IL
Email Formats
Sign up for free credits and discover verified email addresses of Nurexone Biologic (Tsxv: Nrx) (Fse: J90)
FormatExamples
first + last
andywarhol@nurexone.com
first_initial + last
awarhol@nurexone.com
first + last_initial
andyw@nurexone.com
first
andy@nurexone.com
last
warhol@nurexone.com
Frequently Asked Questions
Similar Companies
Biotechnology Research
Get key business info for Nurexone Biologic (Tsxv: Nrx) (Fse: J90) and other 100M companies. Start your seach.
Continue with GoogleNo Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.